.
STX financial statements
* Numbers in millions
Year |
2020 | TTM |
|---|---|---|
Capitalization * |
6 389 | 2 169 |
EV * |
61 | 61 |
Stock price ¤ |
54.5 | 18.5 |
Number of shares * |
117 | 117 |
EPS |
-0,02 | -0,02 |
Revenue * |
10 | 10 |
Net income * |
-3 | -3 |
Operating profit * |
-2 | -2 |
Total liabilities * |
2 | 2 |
Net debt * |
-3 | -3 |
Total assets * |
33 | 33 |
Equity * |
30 | 30 |
Cash and investments * |
3 | 3 |
Over the past 10 years, the maximum capitalization of Shield Therapeutics plc is 6 389, the minimum is 6 389. Maximum net income 0, Minimum net income -3. The maximum price of STX shares is 54.5, the minimum price is 54.5.
.
STX valuation
Year |
2020 | TTM |
|---|---|---|
P/E |
-24,29 | -8,25 |
P/B |
2,11 | 0,72 |
P/S |
6,15 | 2,09 |
E/P |
-4% | -12% |
P/FCF |
-44,90 | -15,24 |
.
STX profitability
Year |
2020 | TTM |
|---|---|---|
ROE |
-9% | |
ROA |
-50% | |
ROIC |
-7% |